SOPHiA GENETICS – Genomic Data and AI-Powered Software as a Service (SaaS) Platform
Dr. Emily Paul, a molecular biologist with a specialty in genetics and Product Director for SOHPiA GENETICS DDMTM discusses processing thousands of genomic profiles for diseases, such as cancer and inherited disorders, where combining genomic and phenotypic information is vital to support discoveries, treatment decisions, and drug development efforts. She talks about how researchers and HCPs can work together by sharing and leveraging patterns identified via AI and machine learning, which improves as it analyzes more data over time.
Dr. Emily Paul is a molecular biologist with a specialty in genetics. She obtained her Ph.D at the State University of New York at Albany and was subsequently a fellow at Wadsworth Center at the New York State Department of Health, the Boston Children’s Hospital, Harvard Medical School and the Dana-Farber Cancer Institute.
She joined SOPHiA GENETICS in 2017 as a Subject Matter Expert, and is now Product Director for SOPHiA DDMTM. She’s presented at many global life science conferences on behalf of SOPHiA GENETICS and has a proven ability of making sometimes complex scientific topics more understandable for those who don’t work in labs every day.
0 Comments